Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones
- PMID: 3484513
- PMCID: PMC2188019
- DOI: 10.1084/jem.163.1.215
Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones
Abstract
The possibility that a single human tumor may be composed of an heterogeneous population of cells with respect to susceptibility to lysis by autologous CTL clones was investigated by testing six cytolytic clones derived by micromanipulation against the autologous metastatic melanoma, Me28, and against 31 clones derived from Me28 by cloning in soft agar. Highly significant differences in the lysis of many tumor clones were observed by three of the CTL effectors in comparison with the cytotoxicity achieved on Me28. These results indicate that cloned cellular reagents can detect heterogeneity among cells isolated from the same melanoma, and suggest that the target determinants recognized on the autologous tumor might be differentially expressed on different neoplastic cells.
Similar articles
-
Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.Int J Cancer. 1985 May 15;35(5):683-9. doi: 10.1002/ijc.2910350518. Int J Cancer. 1985. PMID: 3158614
-
Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.J Immunol. 1984 Jan;132(1):510-9. J Immunol. 1984. PMID: 6197458
-
Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction.J Immunol. 1989 May 15;142(10):3692-701. J Immunol. 1989. PMID: 2469723
-
Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.Cancer Metastasis Rev. 1985;4(1):7-26. doi: 10.1007/BF00047734. Cancer Metastasis Rev. 1985. PMID: 3888384 Review.
-
Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.Int J Cancer. 1993 May 8;54(2):177-80. doi: 10.1002/ijc.2910540202. Int J Cancer. 1993. PMID: 8486420 Review. No abstract available.
Cited by
-
Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.Cancer Metastasis Rev. 1987;5(4):299-312. doi: 10.1007/BF00055375. Cancer Metastasis Rev. 1987. PMID: 3552279 Review.
-
Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.Cancer Immunol Immunother. 1989;30(1):34-42. doi: 10.1007/BF01665028. Cancer Immunol Immunother. 1989. PMID: 2513111 Free PMC article.
-
MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.Cancer Immunol Immunother. 1994 Mar;38(3):185-93. doi: 10.1007/BF01525640. Cancer Immunol Immunother. 1994. PMID: 8124687 Free PMC article.
-
An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma.PLoS One. 2010 Aug 9;5(8):e12014. doi: 10.1371/journal.pone.0012014. PLoS One. 2010. PMID: 20711505 Free PMC article.
-
Human autologous tumor-specific T cells in malignant melanoma.Cancer Metastasis Rev. 1991 Jun;10(2):151-76. doi: 10.1007/BF00049412. Cancer Metastasis Rev. 1991. PMID: 1873855 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical